The clinical response to classical immunosuppressant drugs (cIMDs) is highly variable
among individuals. We performed a systematic review of published evidence supporting the …

Tuberculosis (TB) is a chronic bacterial disease, as well as a complex immune disease. The
occurrence, development, and prognosis of TB are not only related to the pathogenicity of …

The phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin
(P13K/AKT/mTOR) pathway plays a key role in tuberculosis (TB) pathogenesis and infection …

Introduction The emergence of drug-resistant Mycobacterium tuberculosis (Mtb) strains has
underscored the urgent need for novel therapeutic approaches. Carbon-based …

Tuberculosis (TB) is caused by the bacterial pathogen Mycobacterium tuberculosis (MTB)
and is one of the principal reasons for mortality and morbidity worldwide. Currently …